Back

Watch Compare

FRACTYL HEALTH, INC.

Data quality: 83%

GUTS

Nasdaq Manufacturing Measuring & Analyzing Instruments

$0.46

▼ $0.01 (-1.74%)

Mkt Cap: 72.50 M

Price

$0.46

Mkt Cap

72.50 M

Day Range

$0.45 — $0.47

52-Week Range

$0.38 — $3.03

Volume

706,004

Open $0.46

50D / 200D Avg

$0.59

22.24% below

50D / 200D Avg

$1.29

64.54% below

Quick Summary

Key Takeaways

Negative free cash flow of -90.89 M

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROIC-112.67%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio4.27

Interest CoverageN/A

Valuation

PE (TTM)

-0.51

Above sector avg (-1.48)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-0.5	-1.5
P/B	—	1.6
ROE %	—	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-140.95 M
ROE	N/A	ROA	-159.92%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-90.89 M
ROIC	-112.67%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	4.27
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	61.02 M	Tangible Book Value	-3.18 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.51	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-125.35%
Market Cap	72.50 M	Enterprise Value	-5.15 M
Per Share
EPS (Diluted TTM)	-1.86	Revenue / Share	N/A
FCF / Share	-0.57	OCF / Share	-0.57
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	64.48%
SBC-Adj. FCF	-100.93 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024
Revenue	—	—
Net Income	-140.95 M	-68.69 M
EPS (Diluted)	-1.86	-1.62
Gross Profit	43,000.0	43,000.0
Operating Income	-96.82 M	-93.53 M
EBITDA	—	—
R&D Expenses	74.54 M	70.47 M
SG&A Expenses	22.28 M	23.10 M
D&A	—	—
Interest Expense	—	—
Income Tax	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024
Total Assets	121.40 M	108.08 M
Total Liabilities	111.94 M	79.65 M
Shareholders' Equity	9.46 M	28.42 M
Total Debt	—	—
Cash & Equivalents	81.54 M	67.46 M
Current Assets	87.58 M	71.76 M
Current Liabilities	18.33 M	19.78 M